Healthcare IT Today
MARCH 15, 2024
According to BSI’s recent Trust in AI Poll , which surveyed 10,000 adults across nine countries, including the U.S., We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. billion by 2032. Fortunately, consumers are largely excited about AI’s potential in this space.
Henry Kotula
MARCH 10, 2021
The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. As the U.S. Healthcare and pharma companies seem to be more bullish on AI than other industries are. Future AI investment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Society for Participatory Medicine
JANUARY 27, 2022
Patient engagement is measured by Consumer Assessment of Healthcare Processes and Services (CAHPS) surveys & Patient Activation Measures (PAM). Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.
Healthcare IT News - Telehealth
MAY 6, 2020
Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. The eCareCoordinator telehealth software platform allows clinicians to remotely monitor patients’ vital signs and send patients short surveys about their health status.
Insulin Nation
JULY 14, 2015
DiMasi, PhD, who analyzes the economics of health care at the Tufts University Center for the Study of Drug Development. We’ve seen very large trials and lengthening clinical development times, which would suggest larger than average development costs,” DiMasi said. There I listened to a presentation of Joseph A.
Expert insights. Personalized for you.
94 
Let's personalize your content